Spectrum Pharmaceuticals

Aug 17, 2017

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Jun 23, 2017

European Hematology Association: Two is better than one: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses in a Phase 2 Study for Relapsed/Refractory NHL

May 30, 2017

CASI Pharmaceuticals Announces Poster Presentation At ASCO On ENMD-2076 In Patients With Clear Cell Ovarian Carcinoma (CCOC)